Schimmelpennink Evert B.
President, CEO and Secretary
Schimmelpennink Evert B. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 30, 2026.
On the most recent filing, Schimmelpennink Evert B. is listed as President, CEO and Secretary at LENZ Therapeutics, Inc. Inside the rolling window, Schimmelpennink Evert B. reported 1 open-market purchase totaling $251K in LENZ and no open-market sales.
Companies traded
Other insiders at LENZ
Insider Buying
$251K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Schimmelpennink Evert B. made?
Schimmelpennink Evert B. has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Schimmelpennink Evert B. trade?
Schimmelpennink Evert B. has filed SEC Form 4 disclosures for 1 company, including LENZ.
When was Schimmelpennink Evert B.'s most recent SEC Form 4 filing?
Schimmelpennink Evert B.'s most recent SEC Form 4 filing on Tracefour is dated Mar 30, 2026.
What is Schimmelpennink Evert B.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Schimmelpennink Evert B. is listed as President, CEO and Secretary.
What is Schimmelpennink Evert B.'s total buy and sell value in the current window?
Inside the rolling retention window, Schimmelpennink Evert B. bought $251K and sold $0 based on SEC Form 4 filings.
What was Schimmelpennink Evert B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 28,089 LENZ shares on 2026-03-27, worth $251K, per SEC Form 4 filings.